HUL Board approved FY26 results with consolidated revenue of Rs. 63,763 crores, up 5% YoY, and recommended a final dividend of Rs. 22 per share.
Consolidated PAT from continuing operations was Rs. 10,652 crores, while Q4 revenue grew 8% with 6% volume growth, marking the highest growth in 12 quarters.
The company completed acquisition of 100% stake in Zywie Ventures and divested minority stake in Nutritionalab, recognizing Rs. 256 crores profit from the divestment.
Auditors Walker Chandiok & Co LLP issued unmodified opinions on both standalone and consolidated financial results for the year ended 31st March 2026.